Sullivan Eddie Joe Insider Trades

Insider Trading History

Track insider trading activity for Sullivan Eddie Joe. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
PRESIDENT
Holding Value $30k 3,000,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$106k 3,000,000 shares
$0.04
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
PRESIDENT
Holding Value $11.6M 3,000,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.4M 3,000,000 shares
$4.45
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
PRESIDENT
Holding Value $11.6M 3,000,000 shares
Last Trade
Aug 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.51M 3,000,000 shares
$2.17
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
PRESIDENT
Holding Value $30k 3,000,000 shares
Last Trade
Aug 26, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$93.6k 3,000,000 shares
$0.03
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
PRESIDENT
Holding Value $465 46,528 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.95k 50,975 shares
$0.04
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
PRESIDENT
Holding Value $180k 46,528 shares
Last Trade
Jul 15, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$148k 50,975 shares
$2.90
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
PRESIDENT
Holding Value $1.9k 190,000 shares
Last Trade
Feb 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$5.62k 190,000 shares
$0.03
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
PRESIDENT
Holding Value $735k 190,000 shares
Last Trade
Feb 21, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$982k 190,000 shares
$5.17
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
Chief Executive Officer
Holding Value $20.2M 5,232,304 shares
Last Trade
Dec 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$15.5k 1,740 shares
$8.88
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Chief Executive Officer
Holding Value $52.3k 5,232,304 shares
Last Trade
Dec 07, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$87 1,740 shares
$0.05
$0.01
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Chief Executive Officer
Holding Value $5.25k 525,000 shares
Last Trade
Mar 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Chief Executive Officer
Holding Value $2.03M 525,000 shares
Last Trade
Mar 14, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.81M 525,000 shares
$5.35
$3.87
SAB Biotherapeutics
SAB Biotherapeutics SABS
10% owner, CHIEF EXECUTIVE OFFICER
Holding Value $135k 35,000 shares
Last Trade
Sep 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$249k 35,000 shares
$7.11
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
10% owner, CHIEF EXECUTIVE OFFICER
Holding Value $350 35,000 shares
Last Trade
Sep 13, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
CHIEF EXECUTIVE OFFICER
Holding Value $20.2M 5,230,564 shares
Last Trade
Sep 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$95.3k 14,000 shares
$6.81
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
CHIEF EXECUTIVE OFFICER
Holding Value $52.3k 5,230,564 shares
Last Trade
Sep 07, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.01
SAB Biotherapeutics
SAB Biotherapeutics SABS
Chief Executive Officer
Holding Value $82.1k 21,218 shares
Last Trade
Mar 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$378k 21,218 shares
$17.80
$3.87
SAB Biotherapeutics- Warrants (25/07/2027)
SAB Biotherapeutics- Warrants (25/07/2027) SABSW
Chief Executive Officer
Holding Value $212 21,218 shares
Last Trade
Mar 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.01
Big Cypress Acquisition - Warrants (25/07/2027)
Big Cypress Acquisition - Warrants (25/07/2027) BCYPW
10% owner, Chief Executive Officer
Holding Value $217k 197,374 shares
Last Trade
Oct 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$358k 325,699 shares
$1.10
$1.10
Big Cypress Acquisition
Big Cypress Acquisition BCYP
10% owner, Chief Executive Officer
Holding Value $1.67M 197,374 shares
Last Trade
Oct 22, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.75M 325,699 shares
$8.44
$8.44

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up